Literature DB >> 25662892

Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy?

Anna L Parks1, Ryan M McWhirter, Kimberley Evason, Robin K Kelley.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25662892      PMCID： PMC5321609          DOI： 10.1007/s12029-015-9690-7

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  15 in total

1.  Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

Authors:  T Takayama; T Sekine; M Makuuchi; S Yamasaki; T Kosuge; J Yamamoto; K Shimada; M Sakamoto; S Hirohashi; Y Ohashi; T Kakizoe
Journal:  Lancet       Date:  2000-09-02       Impact factor: 79.321

Review 2.  Spontaneous regression of hepatocellular carcinoma: three case reports and a categorized review of the literature.

Authors:  Susana Oquiñena; Mercedes Iñarrairaegui; Juan J Vila; Felix Alegre; Jose M Zozaya; Bruno Sangro
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

3.  Temporary spontaneous regression of intrahepatic cholangiocarcinoma.

Authors:  K Yoshimitsu; H Honda; K Kaneko; T Fukuya; H Irie; H Aibe; K Takenaka; K Kajiyama; K Masuda
Journal:  Comput Med Imaging Graph       Date:  1996 Mar-Apr       Impact factor: 4.790

Review 4.  Potential of immunotherapy for hepatocellular carcinoma.

Authors:  Ekaterina Breous; Robert Thimme
Journal:  J Hepatol       Date:  2010-11-09       Impact factor: 25.083

Review 5.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Andrew Burroughs; Jordi Bruix
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

6.  Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.

Authors:  Jedd D Wolchok; Axel Hoos; Steven O'Day; Jeffrey S Weber; Omid Hamid; Celeste Lebbé; Michele Maio; Michael Binder; Oliver Bohnsack; Geoffrey Nichol; Rachel Humphrey; F Stephen Hodi
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

Review 7.  Vanishing liver tumours.

Authors:  P Peddu; D Huang; P A Kane; J B Karani; A S Knisely
Journal:  Clin Radiol       Date:  2007-11-26       Impact factor: 2.350

Review 8.  Melanoma as a model tumour for immuno-oncology.

Authors:  M Maio
Journal:  Ann Oncol       Date:  2012-09       Impact factor: 32.976

9.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

10.  A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

Authors:  Bruno Sangro; Carlos Gomez-Martin; Manuel de la Mata; Mercedes Iñarrairaegui; Elena Garralda; Pilar Barrera; Jose Ignacio Riezu-Boj; Esther Larrea; Carlos Alfaro; Pablo Sarobe; Juan José Lasarte; Jose L Pérez-Gracia; Ignacio Melero; Jesús Prieto
Journal:  J Hepatol       Date:  2013-03-04       Impact factor: 25.083
View more
  4 in total

1.  Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades.

Authors:  Cheng-Long Han; Yu-Chuan Yan; Lun-Jie Yan; Guang-Xiao Meng; Chun-Cheng Yang; Hui Liu; Zi-Niu Ding; Zhao-Ru Dong; Jian-Guo Hong; Zhi-Qiang Chen; Tao Li
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-28       Impact factor: 4.553

Review 2.  The Promise of Immunotherapy in the Treatment of Hepatocellular Carcinoma.

Authors:  Anthony El-Khoueiry
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

Review 3.  Spontaneous regression of hepatocellular carcinoma: A mini-review.

Authors:  Akira Sakamaki; Kenya Kamimura; Satoshi Abe; Atsunori Tsuchiya; Masaaki Takamura; Hirokazu Kawai; Satoshi Yamagiwa; Shuji Terai
Journal:  World J Gastroenterol       Date:  2017-06-07       Impact factor: 5.742

Review 4.  Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?

Authors:  David Repáraz; Belén Aparicio; Diana Llopiz; Sandra Hervás-Stubbs; Pablo Sarobe
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.